loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 208399 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 TERSERA (1)

filter

01 EMULSION;INTRAVENOUS (1)

filter

01 DISCN (1)

filter

01 VARUBI (1)

filter

01 Yes (1)

URL Supplier Web Content
EMULSION; INTRAVEN...
EQ 166.5MG BASE/92...
2017-10-25
208399
VARUBI
DISCN
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 208399

Looking for FDA Orange Book APPLICATION 208399 1

19

TerSera Therapeutics, based in U.S.A, is a pharmaceutical company.

One of their notable products is ROLAPITANT HYDROCHLORIDE, with a corresponding application number 208399.

Regulatory Information DISCN

With a dosage strength EQ 166.5MG BASE/92.5ML (EQ 1.8MG BASE/ML)

Dosage Form Route EMULSION; INTRAVENOUS

Reference Listed Drug Yes

Approved since 2017-10-25

Post Enquiry
POST ENQUIRY